We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$2B
AUM Growth
+$12.2M
Cap. Flow
-$123M
Cap. Flow %
-6.13%
Top 10 Hldgs %
36.44%
Holding
384
New
60
Increased
76
Reduced
187
Closed
58

Top Buys

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$39.4M
2
HPQ icon
HP
HPQ
+$34M
3
SO icon
Southern Company
SO
+$33.9M
4
CNC icon
Centene
CNC
+$33.7M
5
UGI icon
UGI
UGI
+$33M

Sector Composition

Rank Sector Weight
1 Healthcare 30.15%
2 Technology 21.65%
3 Industrials 12.91%
4 Utilities 10.27%
5 Consumer Staples 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
1
Micron Technology
MU
$930B
$84.8M 4.24%
2,422,836
-123,837
-5% -$4.1M
AGN
2
DELISTED
Allergan plc
AGN
$82.7M 4.13%
321,373
-21,591
-6% -$5.4M
LUV icon
3
Southwest Airlines
LUV
$22B
$80.7M 4.03%
1,907,259
-75,218
-4% -$2.81M
COR icon
4
Cencora
COR
$60.6B
$77.3M 3.86%
857,866
-45,461
-5% -$3.9M
CVS icon
5
CVS Health
CVS
$133B
$73.6M 3.67%
763,706
-9,280
-1% -$818K
DAL icon
6
Delta Air Lines
DAL
$57.5B
$72.8M 3.63%
1,479,235
-68,951
-4% -$2.9M
KDP icon
7
Keurig Dr Pepper
KDP
$42.3B
$69.2M 3.45%
964,988
-42,412
-4% -$2.94M
AEP icon
8
American Electric Power
AEP
$69.6B
$68.3M 3.41%
1,124,456
-50,519
-4% -$2.89M
ELV icon
9
Elevance Health
ELV
$81.5B
$63.8M 3.19%
507,969
-22,439
-4% -$2.77M
BIIB icon
10
Biogen
BIIB
$30B
$56.6M 2.83%
166,873
-8,596
-5% -$2.78M
AVGO icon
11
Broadcom
AVGO
$1.85T
$54.7M 2.73%
5,439,580
-413,590
-7% -$3.7M
SWKS icon
12
Skyworks Solutions
SWKS
$9.37B
$53M 2.65%
729,532
-26,131
-3% -$1.62M
MCK icon
13
McKesson
MCK
$100B
$50.7M 2.53%
244,207
-16,315
-6% -$3.31M
MAR icon
14
Marriott International
MAR
$98.3B
$49.1M 2.45%
629,331
-32,581
-5% -$2.4M
LMT icon
15
Lockheed Martin
LMT
$134B
$47.4M 2.36%
245,922
-10,205
-4% -$1.89M
META icon
16
Meta Platforms (Facebook)
META
$1.42T
$46.9M 2.34%
601,732
-22,583
-4% -$1.73M
NXPI icon
17
NXP Semiconductors
NXPI
$57.8B
$46.5M 2.32%
608,259
-67,647
-10% -$4.8M
FIS icon
18
Fidelity National Information Services
FIS
$23.1B
$46.2M 2.31%
743,297
-36,191
-5% -$2.13M
ILMN icon
19
Illumina
ILMN
$31B
$44.9M 2.24%
249,808
-9,237
-4% -$1.63M
CPAY icon
20
Corpay
CPAY
$25B
$44M 2.2%
295,609
-19,590
-6% -$2.82M
CENX icon
21
Century Aluminum
CENX
$4.43B
$43.4M 2.17%
1,779,842
-67,414
-4% -$1.74M
HNT
22
DELISTED
HEALTH NET INC
HNT
$42.8M 2.14%
+799,779
New +$39.4M
NI icon
23
NiSource
NI
$21.3B
$41.1M 2.05%
2,467,003
-119,287
-5% -$1.94M
CNC icon
24
Centene
CNC
$30.7B
$38.2M 1.91%
1,471,924
+1,443,456
+5,070% +$33.7M
HPQ icon
25
HP
HPQ
$24.9B
$37M 1.85%
+2,031,490
New +$34M

Similar funds

Navellier & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Navellier & Associates held 384 positions worth $2B, up 0.62% from $1.99B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Navellier & Associates withdrew a net $123M in Q4 2014, closing 58 positions and reducing 187 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $71.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, Navellier & Associates opened a new position in HEALTH NET INC worth $42.8M.

  • Navellier & Associates's largest Q4 2014 buy was HEALTH NET INC: 799,779 shares worth $42.8M.
  • Navellier & Associates added most to Southern Company in Q4 2014, an estimated $33.9M increase.
  • Navellier & Associates's biggest Q4 2014 reduction was DuPont de Nemours, cutting an estimated $31.3M.
  • Navellier & Associates fully exited Thermo Fisher Scientific in Q4 2014, selling an estimated $71.9M.
  • Navellier & Associates's ten largest holdings make up 36% of its $2B portfolio in Q4 2014.
  • Navellier & Associates opened 60 new positions and closed 58 in Q4 2014.
  • Navellier & Associates's portfolio value rose 0.62% quarter-over-quarter to $2B.

Based on Navellier & Associates's 13F filing for Q4 2014, filed 2 Feb 2015.